121 related articles for article (PubMed ID: 6152810)
1. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
Reilly FD; Dimlich RV
Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
[TBL] [Abstract][Full Text] [Related]
2. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
Reilly FD; Cilento EV; McCuskey RS
Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
[TBL] [Abstract][Full Text] [Related]
3. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
Reilly FD; Dimlich RV
Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
[TBL] [Abstract][Full Text] [Related]
4. Hepatic microvascular regulatory mechanisms. IX. Effects of compound 48/80 on endotoxin-induced changes in microcirculation and mast cell integrity.
Unger LS; Reilly FD
Microcirc Endothelium Lymphatics; 1986; 3(2):109-28. PubMed ID: 3587176
[TBL] [Abstract][Full Text] [Related]
5. Hepatic microvascular regulatory mechanisms. VII. Effects of endoportally-infused endotoxin on microcirculation and mast cells in rats.
Unger LS; Reilly FD
Microcirc Endothelium Lymphatics; 1986; 3(1):47-74. PubMed ID: 3547067
[TBL] [Abstract][Full Text] [Related]
6. Hepatic microvascular regulatory mechanisms. VIII. Glucogenic responses and morphologic changes following serotonin-induced low flow.
Reilly FD; McCafferty RE; McCuskey PA; Dimlich RV
Microcirc Endothelium Lymphatics; 1986; 3(1):21-46. PubMed ID: 3821692
[TBL] [Abstract][Full Text] [Related]
7. Elevated blood glucose after compound 48/80 treatment is not related to hepatic mast cell degranulation in rats.
Dimlich RV; Reilly FD
Proc Soc Exp Biol Med; 1986 Dec; 183(3):321-7. PubMed ID: 3797416
[TBL] [Abstract][Full Text] [Related]
8. Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats.
Humphreys RA; Kane KA; Parratt JR
J Cardiovasc Pharmacol; 1998 Mar; 31(3):418-23. PubMed ID: 9514187
[TBL] [Abstract][Full Text] [Related]
9. Hepatic microvascular regulatory mechanisms. III. Aminergic mechanisms as related to mast cells.
Reilly FD; Dimlich RV; Cilento EV; McCuskey RS
Int J Microcirc Clin Exp; 1983; 2(1):61-73. PubMed ID: 6678839
[TBL] [Abstract][Full Text] [Related]
10. Improved survival from compound 48/80-induced lethal stress and inhibition of myocardial histamine and carnosine mobilization by lodoxamide.
Flancbaum L; Fitzpatrick JC; Fisher H
Circ Shock; 1989 Feb; 27(2):155-64. PubMed ID: 2706750
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of oxidative enzymes by anti-allergy drugs.
White GJ
Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
[TBL] [Abstract][Full Text] [Related]
12. Effect of H1 and H2 receptor blockers on mobilization of myocardial carnosine to histamine during compound 48/80-induced shock in young rats.
Fitzpatrick JC; Fisher H; Flancbaum L
Circ Shock; 1990 Feb; 30(2):145-53. PubMed ID: 1968787
[TBL] [Abstract][Full Text] [Related]
13. Lodoxamide tromethamine prevents neutrophil accumulation in reexpansion pulmonary edema.
Veal CF; Jackson RM; Brannen AL; Fulmer JD
J Cardiovasc Pharmacol; 1989 Aug; 14(2):227-32. PubMed ID: 2476595
[TBL] [Abstract][Full Text] [Related]
14. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
Johnson HG; Sheridan AQ
Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
[TBL] [Abstract][Full Text] [Related]
15. Mast cell degranulation, hepatic glycogen depletion, and hyperglycemia in Compound 48/80 or pilocarpine-treated rats.
Dimlich RV; Townsend SF; Reilly FD
Hepatology; 1982; 2(3):372-8. PubMed ID: 7076121
[TBL] [Abstract][Full Text] [Related]
16. Allopurinol and lodoxamide in complement-induced hepatic ischemia.
Schirmer WJ; Schirmer JM; Naff GB; Fry DE
J Surg Res; 1988 Jul; 45(1):28-36. PubMed ID: 3260642
[TBL] [Abstract][Full Text] [Related]
17. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury.
Barr ML; Carey JN; Nishanian GP; Roberts RF; Sakamaki Y; Darbinian SH; Starnes VA
J Thorac Cardiovasc Surg; 1998 Mar; 115(3):631-6; discussion 636-7. PubMed ID: 9535451
[TBL] [Abstract][Full Text] [Related]
18. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
19. Effect of lodoxamide on the secretory response induced by Escherichia coli and Vibrio cholerae enterotoxins in infant mice.
Knoop FC; Thomas DD
Infect Immun; 1984 May; 44(2):406-8. PubMed ID: 6143729
[TBL] [Abstract][Full Text] [Related]
20. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
Grutzmacher RD; Foster RS; Feiler LS
Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
